Wong, Ha Kung

Ha Kung Wong has 25 years of experience practicing general intellectual property law with an emphasis on complex patent and trade secret litigation as well as IP transactions and contract negotiations for mergers, acquisitions and collaborations in pharmaceuticals, biologics and chemistry as well as AI. Cases Ha Kung has litigated include those related to proton pump inhibitors, allergy eye drops, anti-epileptic drugs, anti-tussives, antibiotics, injectable microspheres, RNAi products and other pharmaceuticals. Ha Kung also has extensive experience with IPRs, PGRs, Ex Parte Reexam, intellectual property counseling, pre-suit investigations, licensing and due diligence. 

Ha Kung is currently an Advisory Board Member for the Center for Biosimilars, the President-Elect of the Foundation for Advancement of Diversity in IP Law (FADIPL) and serves as faculty for the National Institute of Trial Advocacy (NITA) and Lawline.com.

And, unrelatedly, Ha Kung has an NFL focused podcast and is the regular NFL correspondent for The Platform radio station in New Zealand.